Format

Send to

Choose Destination
Antimicrob Agents Chemother. 1999 Jan;43(1):175-7.

Targeting the shikimate pathway in the malaria parasite Plasmodium falciparum.

Author information

1
Department of Biology, University of Leeds, Leeds LS2 9JT, United Kingdom. g.a.mcconkey@leeds.ac.uk

Abstract

The shikimate pathway presents an attractive target for malaria chemotherapy. Three shikimic acid analogs exhibited different effects on Plasmodium falciparum growth. (6R)-6-Fluoro-shikimate and (6S)-6-fluoro-shikimate inhibited growth (50% inhibitory concentrations, 1.5 x 10(-5) and 2.7 x 10(-4) M, respectively), whereas 2-fluoro-shikimate had no effect. para-Aminobenzoic acid abrogated the inhibition, demonstrating that the shikimate pathway was specifically targeted.

PMID:
9869588
PMCID:
PMC89043
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center